Bank of Montreal posts better-than-expected earnings in third quarter

By sarahako ako
Share

The Canada-based financial services company, Bank of Montreal (BMO), posted better-than-expected earnings in its third quarter, Reuters reports.

The company, which comfortably beat rivals Scotiabank, has seen its shares rise 5% since the start of 2018 with its competitor down 5% since the beginning of the year.

According to Thomson Reuters, BMO revealed that its earnings per share was up 16% to $2.36 in the quarter, which ended on 31 July, compared with the analyst prediction of $2.27.

BMO is currently Canada’s fourth largest lender and saw its net income increase by 34% at the bank’s US business, which is believed to have profited from tax changes.

See more:

Robert Sedran, Canadian Imperial Bank of Commerce analyst, expects that BMO has been aided by demonstrating a strong US performance and also showing its investment banking business which enabled its net income to rise by 7% through stronger trading revenues.

Scotiabank, which is anticipated to having the greatest impact abroad out of Canada’s most important banks, revealed that its net income had increased to $2.26bn from $2.12bn in the same period last year.

In addition, it was found that both Royal Bank of Canada and CIBC achieved better than their respective forecasts last week.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy